Immuron Ltd

Immuron Ltd is an Australian biopharmaceutical company focused on developing and commercialising orally delivered biotherapeutic products, especially polyclonal antibodies. Its core offering is treatment for infectious and inflammatory diseases to meet unaddressed medical needs. The company has a global operational reach. Operating in the biotechnology sector, Immuron Ltd develops orally administered biotherapeutics to help modulate the immune system to address infectious and inflammatory conditions. Its work aims to offer targeted therapeutic and preventative solutions. Monitor the IMRN share price by adding it to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.